UK markets closed

Mithra Pharmaceuticals SA (0R91.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
0.2190-0.0025 (-1.13%)
At close: 05:11PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
62,675
66,997
22,668
9,030
Cost of revenue
20,970
19,623
15,724
3,457
Gross profit
41,705
47,374
6,944
5,573
Operating expenses
Research development
68,909
64,041
85,243
78,458
Selling general and administrative
16,940
16,775
14,386
17,367
Total operating expenses
80,631
73,620
94,820
89,251
Operating income or loss
-38,926
-26,246
-87,876
-83,678
Interest expense
20,377
17,002
11,765
3,503
Income before tax
-33,963
-11,480
-123,769
-110,922
Income tax expense
44,878
48,139
-6,895
-18,835
Income from continuing operations
-78,842
-59,620
-116,875
-92,086
Net income
-78,842
-59,620
-116,875
-92,086
Net income available to common shareholders
-78,842
-59,620
-116,875
-92,086
Basic EPS
-1.41
-1.22
-2.69
-2.25
Diluted EPS
-1.41
-1.22
-2.69
-2.25
Basic average shares
55,087
49,059
43,430
40,988
Diluted average shares
55,087
49,059
43,430
40,988